ArticleOncotarget2017

Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.

Shan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.